Consortium project totaling $7.8 million to develop foundational technology to position bioelectrochemistry as commercially viable for difficult challenges such as CO₂ conversion
SEATTLE, Sept. 30, 2025 /PRNewswire/ — Arzeda, The Protein Design Company™, today announced it has been selected to lead a highly competitive U.S. National Science Foundation (NSF) award under the Ideas Lab: Advancing Cell-Free Systems Toward Increased Range of Use-Inspired Applications (NSF CFIRE) initiative. The award, totaling approximately $7.8 million, will harness Arzeda’s Intelligent Protein Design Technology™ to develop electricity-powered enzyme cascades for sustainable chemical production. This award complements Arzeda’s NSF USPRD selection announced a couple weeks ago, together advancing AI-designed enzymes and cell-free manufacturing.
“Electricity-driven biology unlocks a new manufacturing paradigm,” said Alexandre Zanghellini, Ph.D., cofounder and CEO of Arzeda and Principal Investigator on the award. “With AI-designed enzymes that run directly on electrons, we can bypass many limitations of living cells and build cleaner, more efficient routes for difficult-to-synthesize critical chemicals like methanol.”
Transforming Bioelectrochemistry
Collaborative Ecosystem
Under the award, Arzeda will lead a consortium of academia and industry, including Missouri University of Science and Technology and Novonesis A/S [OTC: NVZMY], a global leader in industrial enzyme manufacturing. The multidisciplinary team will integrate AI enzyme design, synthetic chemistry, and electrochemical engineering to advance cell-free bioelectrodes for industrial adoption.
NSF Acknowledgment
Research reported in this release is supported by the U.S. National Science Foundation: NSF CFIRE award #2453663. Any opinions, findings, and conclusions or recommendations expressed are those of the authors and do not necessarily reflect the views of the NSF. NSF award announcement: https://www.nsf.gov/tip/updates/nsf-invests-more-32m-biotechnology-accelerating-adoption.
About Arzeda
Arzeda develops innovative products powered by its Intelligent Protein Design Technology™, using generative AI-driven design to create, validate, and manufacture new proteins and enzymes that enhance our lives and protect our planet. We commercialize with Fortune 500 go-to-market partners across multiple industries, enabling higher-performing, more cost-effective solutions that are healthier and sustainable. For more information, please visit www.arzeda.com.
Media Contact
pr@arzeda.com
SOURCE Arzeda
Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…
Telehealth Platform Facilitates Compounded Semaglutide and Tirzepatide Access Through Licensed Provider Evaluation as FDA Shortage…
Analysis examines best peptides for boosting growth hormone as ReadyRx lists prescription sermorelin in injectable…
Discover the best fat burner for men in 2025. Explore Wolfson Brand’s effective fat-burning supplements…
Industry Analysis Examines How Cost, Safety, and Access Considerations Shape Semaglutide Choices as MEDVi Lists…
Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex…